Global Protein Degradation Therapy Market Insights, Forecast to 2028

Table Of Contents

1 Report Business Overview

1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Protein Degradation Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 ARV-110 1.2.3 ARV-471 1.2.4 Other 1.3 Market by Application 1.3.1 Global Protein Degradation Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Cancer 1.3.3 Neuroscience 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered2 Global Growth Trends 2.1 Global Protein Degradation Therapy Market Perspective (2017-2028) 2.2 Protein Degradation Therapy Growth Trends by Region 2.2.1 Protein Degradation Therapy Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Protein Degradation Therapy Historic Market Size by Region (2017-2022) 2.2.3 Protein Degradation Therapy Forecasted Market Size by Region (2023-2028) 2.3 Protein Degradation Therapy Market Dynamics 2.3.1 Protein Degradation Therapy Industry Trends 2.3.2 Protein Degradation Therapy Market Drivers 2.3.3 Protein Degradation Therapy Market Challenges 2.3.4 Protein Degradation Therapy Market Restraints3 Competition Landscape by Key Players 3.1 Global Top Protein Degradation Therapy Players by Revenue 3.1.1 Global Top Protein Degradation Therapy Players by Revenue (2017-2022) 3.1.2 Global Protein Degradation Therapy Revenue Market Share by Players (2017-2022) 3.2 Global Protein Degradation Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Protein Degradation Therapy Revenue 3.4 Global Protein Degradation Therapy Market Concentration Ratio 3.4.1 Global Protein Degradation Therapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Protein Degradation Therapy Revenue in 2021 3.5 Protein Degradation Therapy Key Players Head office and Area Served 3.6 Key Players Protein Degradation Therapy Product Solution and Service 3.7 Date of Enter into Protein Degradation Therapy Market 3.8 Mergers & Acquisitions, Expansion Plans4 Protein Degradation Therapy Breakdown Data by Type 4.1 Global Protein Degradation Therapy Historic Market Size by Type (2017-2022) 4.2 Global Protein Degradation Therapy Forecasted Market Size by Type (2023-2028)5 Protein Degradation Therapy Breakdown Data by Application 5.1 Global Protein Degradation Therapy Historic Market Size by Application (2017-2022) 5.2 Global Protein Degradation Therapy Forecasted Market Size by Application (2023-2028)6 North America 6.1 North America Protein Degradation Therapy Market Size (2017-2028) 6.2 North America Protein Degradation Therapy Market Size by Type 6.2.1 North America Protein Degradation Therapy Market Size by Type (2017-2022) 6.2.2 North America Protein Degradation Therapy Market Size by Type (2023-2028) 6.2.3 North America Protein Degradation Therapy Market Share by Type (2017-2028) 6.3 North America Protein Degradation Therapy Market Size by Application 6.3.1 North America Protein Degradation Therapy Market Size by Application (2017-2022) 6.3.2 North America Protein Degradation Therapy Market Size by Application (2023-2028) 6.3.3 North America Protein Degradation Therapy Market Share by Application (2017-2028) 6.4 North America Protein Degradation Therapy Market Size by Country 6.4.1 North America Protein Degradation Therapy Market Size by Country (2017-2022) 6.4.2 North America Protein Degradation Therapy Market Size by Country (2023-2028) 6.4.3 United States 6.4.4 Canada7 Europe 7.1 Europe Protein Degradation Therapy Market Size (2017-2028) 7.2 Europe Protein Degradation Therapy Market Size by Type 7.2.1 Europe Protein Degradation Therapy Market Size by Type (2017-2022) 7.2.2 Europe Protein Degradation Therapy Market Size by Type (2023-2028) 7.2.3 Europe Protein Degradation Therapy Market Share by Type (2017-2028) 7.3 Europe Protein Degradation Therapy Market Size by Application 7.3.1 Europe Protein Degradation Therapy Market Size by Application (2017-2022) 7.3.2 Europe Protein Degradation Therapy Market Size by Application (2023-2028) 7.3.3 Europe Protein Degradation Therapy Market Share by Application (2017-2028) 7.4 Europe Protein Degradation Therapy Market Size by Country 7.4.1 Europe Protein Degradation Therapy Market Size by Country (2017-2022) 7.4.2 Europe Protein Degradation Therapy Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries8 Asia-Pacific 8.1 Asia-Pacific Protein Degradation Therapy Market Size (2017-2028) 8.2 Asia-Pacific Protein Degradation Therapy Market Size by Type 8.2.1 Asia-Pacific Protein Degradation Therapy Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Protein Degradation Therapy Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Protein Degradation Therapy Market Share by Type (2017-2028) 8.3 Asia-Pacific Protein Degradation Therapy Market Size by Application 8.3.1 Asia-Pacific Protein Degradation Therapy Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Protein Degradation Therapy Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Protein Degradation Therapy Market Share by Application (2017-2028) 8.4 Asia-Pacific Protein Degradation Therapy Market Size by Region 8.4.1 Asia-Pacific Protein Degradation Therapy Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Protein Degradation Therapy Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Protein Degradation Therapy Market Size (2017-2028) 9.2 Latin America Protein Degradation Therapy Market Size by Type 9.2.1 Latin America Protein Degradation Therapy Market Size by Type (2017-2022) 9.2.2 Latin America Protein Degradation Therapy Market Size by Type (2023-2028) 9.2.3 Latin America Protein Degradation Therapy Market Share by Type (2017-2028) 9.3 Latin America Protein Degradation Therapy Market Size by Application 9.3.1 Latin America Protein Degradation Therapy Market Size by Application (2017-2022) 9.3.2 Latin America Protein Degradation Therapy Market Size by Application (2023-2028) 9.3.3 Latin America Protein Degradation Therapy Market Share by Application (2017-2028) 9.4 Latin America Protein Degradation Therapy Market Size by Country 9.4.1 Latin America Protein Degradation Therapy Market Size by Country (2017-2022) 9.4.2 Latin America Protein Degradation Therapy Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil10 Middle East & Africa 10.1 Middle East & Africa Protein Degradation Therapy Market Size (2017-2028) 10.2 Middle East & Africa Protein Degradation Therapy Market Size by Type 10.2.1 Middle East & Africa Protein Degradation Therapy Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Protein Degradation Therapy Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Protein Degradation Therapy Market Share by Type (2017-2028) 10.3 Middle East & Africa Protein Degradation Therapy Market Size by Application 10.3.1 Middle East & Africa Protein Degradation Therapy Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Protein Degradation Therapy Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Protein Degradation Therapy Market Share by Application (2017-2028) 10.4 Middle East & Africa Protein Degradation Therapy Market Size by Country 10.4.1 Middle East & Africa Protein Degradation Therapy Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Protein Degradation Therapy Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE11 Key Players Profiles 11.1 Arvinas 11.1.1 Arvinas Company Details 11.1.2 Arvinas Business Overview 11.1.3 Arvinas Protein Degradation Therapy Introduction 11.1.4 Arvinas Revenue in Protein Degradation Therapy Business (2017-2022) 11.1.5 Arvinas Recent Developments 11.2 Nurix Therapeutics 11.2.1 Nurix Therapeutics Company Details 11.2.2 Nurix Therapeutics Business Overview 11.2.3 Nurix Therapeutics Protein Degradation Therapy Introduction 11.2.4 Nurix Therapeutics Revenue in Protein Degradation Therapy Business (2017-2022) 11.2.5 Nurix Therapeutics Recent Developments 11.3 Kymera Therapeutics 11.3.1 Kymera Therapeutics Company Details 11.3.2 Kymera Therapeutics Business Overview 11.3.3 Kymera Therapeutics Protein Degradation Therapy Introduction 11.3.4 Kymera Therapeutics Revenue in Protein Degradation Therapy Business (2017-2022) 11.3.5 Kymera Therapeutics Recent Developments 11.4 C4 Therapeutics 11.4.1 C4 Therapeutics Company Details 11.4.2 C4 Therapeutics Business Overview 11.4.3 C4 Therapeutics Protein Degradation Therapy Introduction 11.4.4 C4 Therapeutics Revenue in Protein Degradation Therapy Business (2017-2022) 11.4.5 C4 Therapeutics Recent Developments12 Analyst's Viewpoints/Conclusions13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer